Fanconi's syndrome associated with prolonged adefovir dipivoxil therapy in a hepatitis B virus patient

Gut and Liver

Volumn 4, Issue 3, 2010, Pages 389-393

  Jung, Young Kul ^a   Yeon, Jong Eun ^b   Choi, Jong Hwan ^b   Kim, Chung Ho ^b   Jung, Eun Suk ^b   Kim, Ji Hoon ^b   Park, Jong Jae ^b   Kim, Jae Seon ^b   Bak, Young Tae ^b   Byun, Kwan Soo ^b  

^a Gachon University College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

Adefovir; Chronic hepatitis B; Fanconi syndrome

Indexed keywords

ADEFOVIR DIPIVOXIL;

AGED; ARTICLE; BONE PAIN; BONE SCINTISCANNING; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; FANCONI RENOTUBULAR SYNDROME; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MALE; OSTEOMALACIA; PHYSICAL EXAMINATION;

EID: 77957598950     PISSN: 19762283     EISSN: None     Source Type: Journal    
DOI: 10.5009/gnl.2010.4.3.389     Document Type: Article

References (27)

1. Earle KE, Seneviratne T, Shaker J, Shoback D. Fanconi's syndrome in HIV+ adults: report of three cases and literature review. J Bone Miner Res 2004;19:714-721.
2. Laing CM, Toye AM, Capasso G, Unwin RJ. Renal tubular acidosis: developments in our understanding of the molecular basis. Int J Biochem Cell Biol 2005;37:1151-1161.
3. Kahn J, Lagakos S, Wulfsohn M, et al. Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial. JAMA 1999;282:2305-2312.
4. Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen- negative chronic hepatitis B. N Engl J Med 2003;348: 800-807.
5. Clarke BL, Wynne AG, Wilson DM, Fitzpatrick LA. Osteomalacia associated with adult Fanconi's syndrome: clinical and diagnostic features. Clin Endocrinol (Oxf) 1995;43:479-490.
6. Fogelman I, McKillop JH, Bessent RG, Boyle IT, Turner JG, Greig WR. The role of bone scanning in osteomalacia. J Nucl Med 1978;19:245-248.
7. Melnick JZ, Baum M, Thompson JR. Aminoglycoside-induced Fanconi's syndrome. Am J Kidney Dis 1994;23:118-122.
8. Yoshikawa H, Watanabe T, Abe T. Fanconi syndrome caused by sodium valproate: report of three severely disabled children. Eur J Paediatr Neurol 2002;6:165-167.
9. Otten J, Vis HL. Acute reversible renal tubular dysfunction following intoxication with methyl-3-chromone. J Pediatr 1968;73:422-425.
10. Vaziri ND, Ness RL, Fairshter RD, Smith WR, Rosen SM. Nephrotoxicity of paraquat in man. Arch Intern Med 1979;139:172-174.
11. Lo JC, Chertow GM, Rennke H, Seifter JL. Fanconi's syndrome and tubulointerstitial nephritis in association with L-lysine ingestion. Am J Kidney Dis 1996;28:614-617.
12. Varavithya W, Chulajata R, Ayudthya PS, Preeyasombat C. Fanconi syndrome caused by degraded tetracycline. J Med Assoc Thai 1971;54:62-67.
13. Negro A, Regolisti G, Perazzoli F, Davoli S, Sani C, Rossi E. Ifosfamide-induced renal Fanconi syndrome with associated nephrogenic diabetes insipidus in an adult patient. Nephrol Dial Transplant 1998;13:1547-1549.
14. Gaspar G, Monereo A, García-Reyne A, de Guzmán M. Fanconi syndrome and acute renal failure in a patient treated with tenofovir: a call for caution. AIDS 2004;18: 351-352.
15. Kazory A, Singapuri S, Wadhwa A, Ejaz AA. Simultaneous development of Fanconi syndrome and acute renal failure associated with cidofovir. J Antimicrob Chemother 2007; 60:193-194.
16. Mathew G, Knaus SJ. Acquired Fanconi's syndrome associated with tenofovir therapy. J Gen Intern Med 2006;21: C3-C5.
17. Parsonage MJ, Wilkins EG, Snowden N, Issa BG, Savage MW. The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy. HIV Med 2005;6:341-346.
18. Schaub TP, Kartenbeck J, König J, et al. Expression of the conjugate export pump encoded by the mrp2 gene in the apical membrane of kidney proximal tubules. J Am Soc Nephrol 1997;8:1213-1221. (Pubitemid 27493625)
19. Sweet DH, Miller DS, Pritchard JB. Localization of an organic anion transporter-GFP fusion construct (rROAT1- GFP) in intact proximal tubules. Am J Physiol 1999;276(6 Pt 2):F864-F873.
20. Masereeuw R, Russel FG, Miller DS. Multiple pathways of organic anion secretion in renal proximal tubule revealed by confocal microscopy. Am J Physiol 1996;271(6 Pt 2): F1173-F1182.
21. König J, Nies AT, Cui Y, Leier I, Keppler D. Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochim Biophys Acta 1999;1461:377-394.
22. Izzedine H, Launay-Vacher V, Isnard-Bagnis C, Deray G. Drug-induced Fanconi's syndrome. Am J Kidney Dis 2003; 41:292-309.
23. Servais A, Lechat P, Zahr N, et al. Tubular transporters and clearance of adefovir. Eur J Pharmacol 2006;540:168-174.
24. Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, et al. Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years. Gastroenterology 2006;131:1743-1751.
25. Lee HJ, Choi JW, Kim TN, Eun JR. A case of severe hypophosphatemia related to adefovir dipivoxil treatment in a patient with liver cirrhosis related to hepatitis B virus. Korean J Hepatol 2008;14:381-386.
26. Graf R, Gossrau R, Merker HJ, Schwabe R, Stahlmann R, Nau H. Enzyme cytochemistry combined with electron microscopy, pharmacokinetics, and clinical chemistry for the evaluation of the effects of steady-state valproic acid concentrations on the mouse. Histochemistry 1985;83:347-358.
27. Knorr M, Schaper J, Harjes M, Mayatepek E, Rosenbaum T. Fanconi syndrome caused by antiepileptic therapy with valproic Acid. Epilepsia 2004;45:868-871.